Gastrointestinal Cancer News

Exercise and psychological interventions provide greater benefit to patients than pharmaceutical drugs for reducing cancer-related fatigue, according to results of a meta-analysis.

Stars, activists, physicians and industry professionals came together on the first day of National Colorectal Cancer Awareness Month for the Countdown to 2018 live broadcast to raise awareness about CRC prevention and screening.

The FDA approved telotristat ethyl tablets for use in combination with somatostatin analog therapy for the treatment of adults with carcinoid syndrome diarrhea.

This month’s top news includes a number of key studies in hematology and oncology.

Adults born in 1990 are twice as likely to be diagnosed with colon cancer and four times as likely to be diagnosed with rectal cancer as people born in 1950, according to a retrospective analysis published in Journal of the National Cancer Institute.

The addition of an in-house specialty pharmacy at a cancer center in Connecticut reduced the amount of time patients waited for oral cancer medications; prevented errors associated with filling, dispensing and taking oral chemotherapy; and improved overall quality of care, according to a study being presented at the Quality Care Symposium.

The addition of cetuximab to chemoradiotherapy was associated with a lower incidence of locoregional failure in patients with squamous cell carcinoma of the anal canal, according to results from the phase 2 Eastern Cooperative Oncology Group—American College of Radiology Imaging Network Cancer Research Group Trial.

Early integration of palliative care for patients with newly diagnosed incurable gastrointestinal and lung cancers improved quality of life, reduced depression symptoms, and enhanced coping with prognosis and communication about end-of-life preferences, according to a randomized clinical trial published in Journal of Clinical Oncology.

Several cancer survivorship care models are available to help integrate primary care providers into the long-term follow-up care of cancer survivors.

A single flexible sigmoidoscopy examination reduced the risk for colorectal cancer by more than a third, and provided continued protection against CRC diagnosis and mortality for at least 17 years, according to results from the U.K. Flexible Sigmoidoscopy Screening Trial.